Research Institute
Filter News
Found 2,564 articles
-
Feinstein Institutes’ Dr. Kevin J. Tracey receives 2023 Hans Wigzell Research Foundation's Science Prize
11/2/2023
The Hans Wigzell Research Foundation announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research, is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.
-
Bayer and Broad Institute extend cancer therapy research collaboration
11/2/2023
Bayer and the Broad Institute of MIT and Harvard have renewed their research alliance, adding five years to a 10-year collaboration that has already yielded three clinical oncology candidates.
-
Stupid Strong Charitable Foundation Pledges $450,000 Grant to Advance Gastric Cancer Family Study
11/1/2023
The Stupid Strong Charitable Foundation is proud to announce a significant commitment of $450,000 in grant funding over four years to support a groundbreaking research project at The University of Texas MD Anderson Cancer Center.
-
Florida Cancer Specialists & Research Institute Launches Advanced Cellular Therapy Program to Treat Recurring Blood Cancers
10/31/2023
Florida Cancer Specialists & Research Institute, LLC is now offering an advanced maintenance therapy program that slows the progression of relapsed/refractory multiple myeloma.
-
Research Institute Announces Major Staffing Expansion
10/31/2023
The recent addition of five senior research scientists and 40 research support staff members represents a near doubling in size of Chestnut Health Systems™' Lighthouse Institute.
-
Cancer Research Institute Awards Ananda Goldrath, Ph.D., with the 2023 Frederick W. Alt Award
10/30/2023
The Cancer Research Institute has awarded Ananda Goldrath, Ph.D., Executive Vice President and Director of the Allen Institute for Immunology, the 2023 Frederick W. Alt Award.
-
RevBio Awarded a $2 Million Follow-On NIH Grant to Reduce Opioid Use and Addiction with TETRANITE®
10/25/2023
RevBio, Inc., announced that it has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, to improve strategies for the prevention and treatment of opioid misuse and addiction.
-
Feinstein Institutes Awarded $6.1M to Fund Bipolar Disorder Patient and Research Hub
10/19/2023
Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.
-
Florida Cancer Specialists & Research Institute Optimizing Use of Anticancer Drugs to Improve Care for Patients with Blood Disorders
10/18/2023
A best practice clinical program developed by Florida Cancer Specialists & Research Institute, LLC is ensuring that patients with certain blood disorders achieve maximum clinical benefits from the use of oral medications.
-
Ivy Brain Tumor Center Announces Results of Phase 0/1 Study in Recurrent Glioblastoma Patients at the European Society for Medical Oncology (ESMO) 2023 Congress
10/18/2023
The Ivy Brain Tumor Center at Barrow Neurological Institute announced initial results from a Phase 0/1 clinical trial of the Ataxia telangiectasia mutated kinase inhibitor AZD1390 in recurrent glioblastoma in combination with radiation therapy.
-
LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration
10/16/2023
LIXTE Biotechnology Holdings, Inc. announced that it has signed an agreement to expand its collaboration with the Netherlands Cancer Institute and Oncode Institute to study drug synergies of LIXTE’s lead clinical compound, LB-100, with immunotherapy in various cancers.
-
City of Hope and TGen Research Reveals What Potentially Causes a Leukemia to Become More Aggressive
10/11/2023
Scientists with City of Hope®, one of the largest cancer research and treatment organizations in the United States, and the Translational Genomics Research Institute, part of City of Hope, may have discovered one of the causes for a type of leukemia to develop into a more aggressive form, according to recent research published in Nature Communications.
-
Rady Children's Researcher Awarded $4 Million
10/10/2023
The National Institutes of Health and the National Cancer Institute recently awarded a $4 million Research Project Grant to Paula Aristizabal, MD, MAS, pediatric oncologist at Rady Children's Hospital-San Diego and Associate Professor of Pediatrics in Pediatric Hematology/Oncology at the University of California San Diego and Moores Cancer Center to expand a pilot program aimed at improving diverse participation in pediatric cancer clinical trials.
-
Florida Cancer Specialists & Research Institute Announces Bradley Monk, MD as Medical Director of Late-Phase Clinical Research Program
10/10/2023
Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Bradley Monk, MD will join the statewide practice as Medical Director of Late-Phase Research, effective January 1, 2024.
-
John D. Carpten, Ph.D., City of Hope’s Chief Scientific Officer, Elected to Prestigious National Academy of Medicine
10/9/2023
John D. Carpten, Ph.D., chief scientific officer at City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, was presented with one of the highest honors in health and medicine when he was elected to the National Academy of Medicine.
-
Hongkui Zeng, Ph.D., Executive Vice President, Director of the Allen Institute for Brain Science, Elected to National Academy of Medicine
10/9/2023
Oct. 9, 2023 at their annual general meeting, the National Academy of Medicine announced the election of Hongkui Zeng, Ph.D, Allen Institute's Executive Vice President and Director of the Allen Institute for Brain Science, to their membership for her leading role in understanding the cell types and the functional architecture of the mammalian brain.
-
Feinstein Institutes secures $4M from NIH to study Black maternal health interventions
10/5/2023
From excessive bleeding to high blood pressure, even death, poor maternal health outcomes before or after delivery are at an all-time high across the United States, particularly for Black birthing people.
-
American Lung Association Invests in Critical Work to Create Universal Flu Shot
10/4/2023
The American Lung Association Research Institute announced a three-year, $500,000 grant to Texas Biomedical Research Institute to help accelerate its efforts to develop a universal flu vaccine.
-
The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
10/3/2023
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford.
-
OpenFold Drug Discovery AI Research Consortium Announces Funding of Large-Scale Protein Data Collection at Prof. Gabriel Rocklin’s Laboratory at Northwestern University
10/2/2023
The OpenFold group, a non-profit artificial intelligence research consortium of biotech and tech firms whose goal is to develop free and open-source software tools for biology and drug discovery, is announcing the funding of new large-scale protein studies at Prof. Gabriel Rocklin’s laboratory at Northwestern University.